Roche’s Avastin plus chemotherapy receives positive recommendation from CHMP
Roche announced the EU’s Committee for Medicinal Products for Human Use has issued a positive opinion on the use of Avastin (bevacizumab) in combination with standard chemotherapy for treatment of adult patients with persistent, recurrent or metastatic carcinoma of the cervix. February 27, 2015